Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RBM39 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CALU - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPMT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP2K4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LUC7L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FARP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRPRA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
NGRN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TIGD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM32A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAMD4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBFOX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DICER1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on